Skip to content

Comprehensive geriatric assessment in a HAH setting

A multi-centre randomised controlled trial to compare the effectiveness of admission avoidance hospital at home with comprehensive geriatric assessment vs. inpatient comprehensive geriatric assessment on the number of frail older people living at home?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN60477865
Enrollment
1055
Registered
2014-10-03
Start date
2014-11-30
Completion date
Unknown
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Primary Care, Ageing

Interventions

CGA in hospital at home: Admission avoidance HaH with CGA is a specialist led service providing assessment and a tailored management plan, multidisciplinary management and coordinated care in the pati
Study Entry : Single Randomisation only

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Older patients with frailty who are aged >65 years and who have been referred to the admission avoidance HaH service with CGA and who would otherwise require admission to hospital for an acute medical event. This will include patients presenting with delirium, functional decline, dependence, falls, immobility or a background of dementia presenting with physical disease

Exclusion criteria

Exclusion criteria: 1. Patient with acute coronary syndrome 2. Patients needing acute surgical assessment 3. Patients presenting with a suspected stroke 4. Patients who are receiving end of life care as part of a palliative care pathway 5. Patients who refuse the HaH service 6. Patients considered by the clinical staff to be too high risk for home based care, for example those who are physiologically unstable, who are at risk to themselves or if the carer reports HaH care would not be acceptable (in keeping with existing clinical practices for HaH) 7. The presence of a carer will not be a requirement for enrolment and will depend on the individual circumstances of the patient; this will be at the discretion of the clinician responsible for the patient (as is current clinical practice in each centre)

Design outcomes

Primary

MeasureTime frame
Living at home; Timepoint(s): 6 and 12 months

Secondary

MeasureTime frame
1. Activities of daily living; Timepoint(s): 6 and 12 months 2. Cognitive impairment; Timepoint(s): 6 and 12 months 3. Delirium; Timepoint(s): 3 and 5 days, 1 month 4. Mortality; Timepoint(s): 6 and 12 months 5. New long-term residential care; Timepoint(s): 6 and 12 months 6. Quality of life; Timepoint(s): 6 and 12 months 7. Resource use; Timepoint(s): 6 and 12 months 8. Transfer to hospital; Timepoint(s): 6 and 12 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 8, 2026